.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Dow
AstraZeneca
Cantor Fitzgerald
Johnson and Johnson
US Department of Justice
Fuji
Merck
Harvard Business School
Mallinckrodt

Generated: September 26, 2017

DrugPatentWatch Database Preview

Pimecrolimus - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pimecrolimus and what is the scope of pimecrolimus patent protection?

Pimecrolimus
is the generic ingredient in one branded drug marketed by Valeant Bermuda and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for pimecrolimus. Two suppliers are listed for this compound.

Summary for Generic Name: pimecrolimus

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list53
Clinical Trials: see list51
Patent Applications: see list4,373
Therapeutic Class:Dermatological Agents
Drug Prices:see low prices
DailyMed Link:pimecrolimus at DailyMed

Pharmacology for Ingredient: pimecrolimus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Bermuda
ELIDEL
pimecrolimus
CREAM;TOPICAL021302-001Dec 13, 2001RXYesYes► Subscribe► Subscribe ► Subscribe
Valeant Bermuda
ELIDEL
pimecrolimus
CREAM;TOPICAL021302-001Dec 13, 2001RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pimecrolimus

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Bermuda
ELIDEL
pimecrolimus
CREAM;TOPICAL021302-001Dec 13, 2001► Subscribe► Subscribe
Valeant Bermuda
ELIDEL
pimecrolimus
CREAM;TOPICAL021302-001Dec 13, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Teva
QuintilesIMS
Julphar
Daiichi Sankyo
AstraZeneca
Chubb
Fuji
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot